CN Stock MarketDetailed Quotes

000952 Hubei Guangji Pharmaceutical

Watchlist
  • 5.26
  • +0.23+4.57%
Market Closed Jun 7 15:00 CST
1.86BMarket Cap-12674P/E (TTM)

Hubei Guangji Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
56.27%180.16M
-7.50%737.82M
-2.57%522.49M
-8.54%343.91M
-13.49%115.29M
1.54%797.64M
12.59%536.28M
16.30%376.02M
-24.42%133.27M
14.15%785.57M
Operating revenue
56.27%180.16M
-7.50%737.82M
-2.57%522.49M
-8.54%343.91M
-13.49%115.29M
1.54%797.64M
12.59%536.28M
16.30%376.02M
-24.42%133.27M
14.15%785.57M
Other operating revenue
----
176.27%7.71M
----
2,850.02%4.37M
----
494.89%2.79M
----
-82.77%147.98K
----
-62.69%469.09K
Total operating cost
49.09%239.27M
15.00%862.66M
11.88%591.55M
2.42%367.96M
19.43%160.48M
6.34%750.16M
26.16%528.71M
26.37%359.25M
-15.47%134.38M
10.92%705.44M
Operating cost
59.92%150.66M
6.58%535.62M
6.19%371.86M
-5.46%237.97M
4.36%94.21M
3.76%502.53M
24.92%350.19M
24.87%251.71M
-23.15%90.27M
18.55%484.33M
Operating tax surcharges
-13.02%3.54M
1.39%13.69M
0.14%9.94M
1.16%6.87M
18.84%4.07M
-15.45%13.5M
-16.66%9.93M
-18.35%6.79M
-14.64%3.42M
22.80%15.97M
Operating expense
6.88%10.44M
15.03%38.64M
24.84%29.03M
37.71%22.33M
106.17%9.76M
10.87%33.59M
49.22%23.25M
72.96%16.21M
-15.22%4.74M
6.27%30.3M
Administration expense
62.31%50.22M
34.24%156.19M
21.67%104.42M
25.02%61.8M
40.02%30.94M
8.74%116.35M
20.10%85.82M
23.52%49.43M
2.93%22.1M
-2.74%107M
Financial expense
64.06%8.32M
187.73%43.77M
244.53%27.36M
104.81%11.85M
8.67%5.07M
-3.64%15.21M
-26.67%7.94M
-9.86%5.79M
59.45%4.67M
-57.50%15.79M
-Interest expense (Financial expense)
68.45%9.34M
132.93%49.15M
124.88%31.93M
62.52%15.31M
16.67%5.54M
26.29%21.1M
21.75%14.2M
38.15%9.42M
60.96%4.75M
-47.71%16.71M
-Interest Income (Financial expense)
-11.52%-613.08K
-72.70%-3.46M
-78.39%-2.45M
-60.43%-1.51M
-29.12%-549.77K
37.90%-2M
39.05%-1.37M
27.11%-943.52K
36.16%-425.79K
-128.50%-3.23M
Research and development
-2.05%16.1M
8.37%74.75M
-5.11%48.94M
-7.45%27.14M
78.90%16.43M
32.49%68.98M
77.99%51.57M
57.76%29.32M
22.37%9.19M
34.28%52.06M
Credit Impairment Loss
-352.74%-1.25M
99.38%-27.48K
27.34%-3.33M
-25.44%-4.04M
243.16%492.63K
-327.64%-4.45M
-206.87%-4.59M
-167.05%-3.22M
71.72%-344.1K
1,285.25%1.95M
Asset Impairment Loss
-190.29%-741.26K
-85.55%-14.26M
254.61%2.32M
310.08%2.68M
139.65%821.01K
-148.47%-7.69M
114.11%652.85K
123.72%652.85K
-689.73%-2.07M
40.66%-3.09M
Other net revenue
2,863.21%2.92M
-221.95%-16.22M
-140.99%-4.37M
-138.51%-3.95M
-101.08%-105.76K
-65.06%13.3M
-57.90%10.65M
-62.03%10.26M
1,724.39%9.84M
-14.75%38.06M
Invest income
71.36%-855.48K
-259.03%-10.02M
-241.43%-6.99M
-209.47%-5.09M
-150.83%-2.99M
-66.34%6.3M
-73.72%4.94M
-75.50%4.65M
580.51%5.88M
-41.80%18.72M
-Including: Investment income associates
71.36%-855.48K
-305.89%-8.93M
-266.08%-6.99M
-215.80%-5.09M
-147.99%-2.99M
-74.71%4.34M
-75.93%4.21M
-75.64%4.4M
467.08%6.22M
458.13%17.15M
Asset deal income
--84.38K
105.88%253.34K
----
----
--0
-891.92%-4.31M
----
----
---9.62K
199.41%543.85K
Other revenue
262.32%5.68M
-66.52%7.85M
-62.23%3.64M
-69.30%2.51M
-75.44%1.57M
17.55%23.43M
41.33%9.65M
36.90%8.17M
96.98%6.38M
12.79%19.94M
Operating profit
-24.04%-56.19M
-332.07%-141.05M
-502.90%-73.42M
-203.61%-28M
-618.97%-45.3M
-48.58%60.78M
-77.92%18.22M
-59.08%27.02M
-51.23%8.73M
22.06%118.2M
Add:Non operating Income
350,685.78%1.07M
33.21%1.2M
1.99%916.89K
-97.15%13.06K
-99.85%306
-86.20%899.42K
-6.89%898.98K
9,059.77%457.99K
4,059.76%207.99K
1,851.35%6.52M
Less:Non operating expense
-82.38%91.67K
-49.22%811.45K
-50.85%717.04K
-48.23%645.47K
-57.59%520.16K
322.34%1.6M
460.81%1.46M
2,798.16%1.25M
3,566.18%1.23M
-95.81%378.36K
Total profit
-20.49%-55.2M
-334.12%-140.67M
-514.53%-73.22M
-209.14%-28.63M
-694.28%-45.82M
-51.68%60.08M
-78.78%17.66M
-60.25%26.23M
-56.85%7.71M
41.06%124.34M
Less:Income tax cost
-27.45%-535.01K
-5.25%11.75M
-133.40%-1.42M
-116.76%-501.75K
-872.81%-419.79K
-33.09%12.4M
-104.89%-610.16K
-63.19%2.99M
-98.90%54.32K
3.83%18.53M
Net profit
FPtoL-54.67M
SL-152.41M
SL-71.79M
SL-28.13M
SL-45.4M
-54.93%47.68M
-74.18%18.27M
-59.84%23.24M
-40.82%7.66M
50.51%105.81M
Net profit from continuing operation
-20.42%-54.67M
-419.63%-152.41M
-492.90%-71.79M
-221.04%-28.13M
-693.01%-45.4M
-54.93%47.68M
-74.18%18.27M
-59.84%23.24M
-40.82%7.66M
50.51%105.81M
Less:Minority Profit
-206.02%-4.16M
-359.16%-12.17M
-194.82%-4.82M
-59.13%-2.32M
-94.09%-1.36M
38.37%-2.65M
52.23%-1.63M
21.73%-1.46M
22.40%-700.59K
1.12%-4.3M
Net profit of parent company owners
-14.69%-50.51M
-378.64%-140.25M
-436.44%-66.98M
-204.49%-25.8M
-627.02%-44.04M
-54.29%50.33M
-73.16%19.91M
-58.65%24.7M
-39.62%8.36M
47.50%110.11M
Earning per share
Basic earning per share
-14.71%-0.1427
-376.48%-0.3962
-435.46%-0.1892
-203.70%-0.0729
-611.93%-0.1244
-55.23%0.1433
-73.84%0.0564
-59.50%0.0703
-56.29%0.0243
43.41%0.3201
Diluted earning per share
-14.71%-0.1427
-376.24%-0.3942
-427.90%-0.1892
-201.82%-0.0729
-624.89%-0.1244
-55.42%0.1427
-73.24%0.0577
-58.76%0.0716
-57.37%0.0237
43.41%0.3201
Other composite income
-265.79%-4.54K
116.26%13.97K
154.63%6.19K
263.92%17.36K
136.05%2.74K
111.95%6.46K
67.18%-11.33K
52.85%-10.59K
-7.59K
-464.63%-54.05K
Other composite income of parent company owners
-265.79%-4.54K
116.26%13.97K
154.63%6.19K
263.92%17.36K
136.05%2.74K
111.95%6.46K
67.18%-11.33K
52.85%-10.59K
---7.59K
-464.63%-54.05K
Total composite income
-20.44%-54.67M
-419.56%-152.4M
-493.11%-71.79M
-221.02%-28.11M
-693.56%-45.4M
-54.90%47.69M
-74.18%18.26M
-59.84%23.23M
-40.88%7.65M
50.40%105.75M
Total composite income of parent company owners
-14.71%-50.51M
-378.57%-140.23M
-436.60%-66.97M
-204.46%-25.79M
-627.46%-44.04M
-54.26%50.34M
-73.17%19.9M
-58.65%24.69M
-39.67%8.35M
47.40%110.05M
Total composite income of minority owners
-206.02%-4.16M
-359.16%-12.17M
-194.82%-4.82M
-59.13%-2.32M
-94.09%-1.36M
38.37%-2.65M
52.23%-1.63M
21.73%-1.46M
22.40%-700.59K
1.12%-4.3M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 56.27%180.16M-7.50%737.82M-2.57%522.49M-8.54%343.91M-13.49%115.29M1.54%797.64M12.59%536.28M16.30%376.02M-24.42%133.27M14.15%785.57M
Operating revenue 56.27%180.16M-7.50%737.82M-2.57%522.49M-8.54%343.91M-13.49%115.29M1.54%797.64M12.59%536.28M16.30%376.02M-24.42%133.27M14.15%785.57M
Other operating revenue ----176.27%7.71M----2,850.02%4.37M----494.89%2.79M-----82.77%147.98K-----62.69%469.09K
Total operating cost 49.09%239.27M15.00%862.66M11.88%591.55M2.42%367.96M19.43%160.48M6.34%750.16M26.16%528.71M26.37%359.25M-15.47%134.38M10.92%705.44M
Operating cost 59.92%150.66M6.58%535.62M6.19%371.86M-5.46%237.97M4.36%94.21M3.76%502.53M24.92%350.19M24.87%251.71M-23.15%90.27M18.55%484.33M
Operating tax surcharges -13.02%3.54M1.39%13.69M0.14%9.94M1.16%6.87M18.84%4.07M-15.45%13.5M-16.66%9.93M-18.35%6.79M-14.64%3.42M22.80%15.97M
Operating expense 6.88%10.44M15.03%38.64M24.84%29.03M37.71%22.33M106.17%9.76M10.87%33.59M49.22%23.25M72.96%16.21M-15.22%4.74M6.27%30.3M
Administration expense 62.31%50.22M34.24%156.19M21.67%104.42M25.02%61.8M40.02%30.94M8.74%116.35M20.10%85.82M23.52%49.43M2.93%22.1M-2.74%107M
Financial expense 64.06%8.32M187.73%43.77M244.53%27.36M104.81%11.85M8.67%5.07M-3.64%15.21M-26.67%7.94M-9.86%5.79M59.45%4.67M-57.50%15.79M
-Interest expense (Financial expense) 68.45%9.34M132.93%49.15M124.88%31.93M62.52%15.31M16.67%5.54M26.29%21.1M21.75%14.2M38.15%9.42M60.96%4.75M-47.71%16.71M
-Interest Income (Financial expense) -11.52%-613.08K-72.70%-3.46M-78.39%-2.45M-60.43%-1.51M-29.12%-549.77K37.90%-2M39.05%-1.37M27.11%-943.52K36.16%-425.79K-128.50%-3.23M
Research and development -2.05%16.1M8.37%74.75M-5.11%48.94M-7.45%27.14M78.90%16.43M32.49%68.98M77.99%51.57M57.76%29.32M22.37%9.19M34.28%52.06M
Credit Impairment Loss -352.74%-1.25M99.38%-27.48K27.34%-3.33M-25.44%-4.04M243.16%492.63K-327.64%-4.45M-206.87%-4.59M-167.05%-3.22M71.72%-344.1K1,285.25%1.95M
Asset Impairment Loss -190.29%-741.26K-85.55%-14.26M254.61%2.32M310.08%2.68M139.65%821.01K-148.47%-7.69M114.11%652.85K123.72%652.85K-689.73%-2.07M40.66%-3.09M
Other net revenue 2,863.21%2.92M-221.95%-16.22M-140.99%-4.37M-138.51%-3.95M-101.08%-105.76K-65.06%13.3M-57.90%10.65M-62.03%10.26M1,724.39%9.84M-14.75%38.06M
Invest income 71.36%-855.48K-259.03%-10.02M-241.43%-6.99M-209.47%-5.09M-150.83%-2.99M-66.34%6.3M-73.72%4.94M-75.50%4.65M580.51%5.88M-41.80%18.72M
-Including: Investment income associates 71.36%-855.48K-305.89%-8.93M-266.08%-6.99M-215.80%-5.09M-147.99%-2.99M-74.71%4.34M-75.93%4.21M-75.64%4.4M467.08%6.22M458.13%17.15M
Asset deal income --84.38K105.88%253.34K----------0-891.92%-4.31M-----------9.62K199.41%543.85K
Other revenue 262.32%5.68M-66.52%7.85M-62.23%3.64M-69.30%2.51M-75.44%1.57M17.55%23.43M41.33%9.65M36.90%8.17M96.98%6.38M12.79%19.94M
Operating profit -24.04%-56.19M-332.07%-141.05M-502.90%-73.42M-203.61%-28M-618.97%-45.3M-48.58%60.78M-77.92%18.22M-59.08%27.02M-51.23%8.73M22.06%118.2M
Add:Non operating Income 350,685.78%1.07M33.21%1.2M1.99%916.89K-97.15%13.06K-99.85%306-86.20%899.42K-6.89%898.98K9,059.77%457.99K4,059.76%207.99K1,851.35%6.52M
Less:Non operating expense -82.38%91.67K-49.22%811.45K-50.85%717.04K-48.23%645.47K-57.59%520.16K322.34%1.6M460.81%1.46M2,798.16%1.25M3,566.18%1.23M-95.81%378.36K
Total profit -20.49%-55.2M-334.12%-140.67M-514.53%-73.22M-209.14%-28.63M-694.28%-45.82M-51.68%60.08M-78.78%17.66M-60.25%26.23M-56.85%7.71M41.06%124.34M
Less:Income tax cost -27.45%-535.01K-5.25%11.75M-133.40%-1.42M-116.76%-501.75K-872.81%-419.79K-33.09%12.4M-104.89%-610.16K-63.19%2.99M-98.90%54.32K3.83%18.53M
Net profit FPtoL-54.67MSL-152.41MSL-71.79MSL-28.13MSL-45.4M-54.93%47.68M-74.18%18.27M-59.84%23.24M-40.82%7.66M50.51%105.81M
Net profit from continuing operation -20.42%-54.67M-419.63%-152.41M-492.90%-71.79M-221.04%-28.13M-693.01%-45.4M-54.93%47.68M-74.18%18.27M-59.84%23.24M-40.82%7.66M50.51%105.81M
Less:Minority Profit -206.02%-4.16M-359.16%-12.17M-194.82%-4.82M-59.13%-2.32M-94.09%-1.36M38.37%-2.65M52.23%-1.63M21.73%-1.46M22.40%-700.59K1.12%-4.3M
Net profit of parent company owners -14.69%-50.51M-378.64%-140.25M-436.44%-66.98M-204.49%-25.8M-627.02%-44.04M-54.29%50.33M-73.16%19.91M-58.65%24.7M-39.62%8.36M47.50%110.11M
Earning per share
Basic earning per share -14.71%-0.1427-376.48%-0.3962-435.46%-0.1892-203.70%-0.0729-611.93%-0.1244-55.23%0.1433-73.84%0.0564-59.50%0.0703-56.29%0.024343.41%0.3201
Diluted earning per share -14.71%-0.1427-376.24%-0.3942-427.90%-0.1892-201.82%-0.0729-624.89%-0.1244-55.42%0.1427-73.24%0.0577-58.76%0.0716-57.37%0.023743.41%0.3201
Other composite income -265.79%-4.54K116.26%13.97K154.63%6.19K263.92%17.36K136.05%2.74K111.95%6.46K67.18%-11.33K52.85%-10.59K-7.59K-464.63%-54.05K
Other composite income of parent company owners -265.79%-4.54K116.26%13.97K154.63%6.19K263.92%17.36K136.05%2.74K111.95%6.46K67.18%-11.33K52.85%-10.59K---7.59K-464.63%-54.05K
Total composite income -20.44%-54.67M-419.56%-152.4M-493.11%-71.79M-221.02%-28.11M-693.56%-45.4M-54.90%47.69M-74.18%18.26M-59.84%23.23M-40.88%7.65M50.40%105.75M
Total composite income of parent company owners -14.71%-50.51M-378.57%-140.23M-436.60%-66.97M-204.46%-25.79M-627.46%-44.04M-54.26%50.34M-73.17%19.9M-58.65%24.69M-39.67%8.35M47.40%110.05M
Total composite income of minority owners -206.02%-4.16M-359.16%-12.17M-194.82%-4.82M-59.13%-2.32M-94.09%-1.36M38.37%-2.65M52.23%-1.63M21.73%-1.46M22.40%-700.59K1.12%-4.3M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg